Supreme Court prompts another look at genetic patents

Myriad gene patent ruling sent back to lower court | Reuters
WASHINGTON (Reuters) - The U.S. Supreme Court on Monday set aside a ruling that said Myriad Genetics Inc could patent two genes linked to breast and ovarian cancers, and ordered further review by a lower